Milan Consensus Endpoints for Bladder Preservation in MIBC

Journal of Clinical Oncology (JCO) Podcast by Journals Online Team

Dec 11, 202527:18Science & Medicine

Guests Dr. Andrea Necchi, Dr. Ashish Kamat and host Dr. Davide Soldato discuss JCO article " End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer ," foc...

Related Episodes

Continue listening to more episodes from Journal of Clinical Oncology (JCO) Podcast.

Phase 2 Study of Multi-Cancer Detection from Breath Samples

Jun 11, 2026 - 20:18

Guests Akash Kulgod and Dr. Sanjeev Kulgod and host Dr. Davide Soldato discuss JCO article, " Canine Olfa...

JCO at ASCO 2026: Individualized Neoantigen Therapy Plus Pembrolizumab in Melanoma

Jun 1, 2026 - 10:28

JCO Editorial Fellow Dr. Ash Gurumurthi and JCO Associate Editor Dr. Grant McArthur discuss the ASCO 2026...

JCO at ASCO 2026: Pemigatinib Phase 3 FIGHT-302 Trial in Cholangiocarcinoma

Jun 1, 2026 - 12:05

JCO Podcast host Dr. Davide Soldato and JCO Associate Editor Dr. Dr. Eileen M. O'Reilly discuss the ASCO...

JCO at ASCO 2026: Individual Patient Pooled Analysis of Low-Dose Tamoxifen in DCIS

May 31, 2026 - 11:19

JCO Editorial Fellow Dr. Yuvanesh Vedaraju and JCO Associate Editor Dr. Kathy Miller discuss the ASCO 202...

JCO at ASCO 2026: Neoadjuvant Sacituzumab in MIBC

May 31, 2026 - 08:56

JCO Editorial Fellow Dr. Jake New and JCO Associate Editor Dr. Umang Swami discuss the ASCO 2026 Simultan...

JCO at ASCO 2026: Intravesical Recombinant BCG with Chemo-Immunotherapy in MIBC

May 29, 2026 - 13:08

JCO Editorial Fellow Dr. Jake New and JCO Associate Editor Dr. Andrea Necchi discuss the ASCO 2026 Simult...

Adjuvant Durvalumab and the Future of Early-Stage NSCLC

May 14, 2026 - 20:04

Guest Dr. Glenwood Goss and host Dr. Davide Soldato discuss JCO article, " Adjuvant Durvalumab in Complet...

JCO Article Insights: LEAP-010 Study in Recurrent/Metastatic Head and Neck Cancer

Apr 27, 2026 - 10:41

Host Jake New summarizes and offers insights into the JCO article by Licitra et al., "Pembrolizumab With...